Skip to main content

Table 2 Effectiveness outcomes

From: A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care

Through 6 months (Effectiveness) Baseline value—control clinics Slope of control clinics (95% CI) p value (pre-post within control clinics) Baseline value—intervention clinics Slope of intervention clinics (95% CI) p value (pre-post within intervention clinics) Slope of intervention minus control (95% CI) p value (difference between intervention—control groups)
Proportion of patients with consistent opioid Rx a 0.014 − 0.0001 (0.0000, − 0.00002) 0.152 0.013 − 0.0002 (− 0.0001, − 0.0003) 0.011 − 0.0001 (0.0000, − 0.0002) 0.237
Proportion with mental health screen b 0.220 0.029 (0.052, 0.006) 0.020 0.226 0.058 (0.079, 0.038) 0.009 0.029 (0.053, 0.005) 0.024
Proportion with urine drug testing b 0.374 0.011 (0.035, − 0.013) 0.025 0.399 0.041 (0.061, 0.020) 0.009 0.029 (0.050, 0.008) 0.011
Proportion with treatment agreement b 0.368 0.029 (0.050, 0.009) 0.009 0.428 0.059 (0.080, 0.038) 0.010 0.03 (0.051, 0.008) 0.012
Average morphine- equivalent daily dose (MEDD) b 58.8 0.245 (−2.08, 2.57) 0.646 86.3 −0.337 (1.07, −1.75) 0.449 −0.581 (0.75, − 1.92) 0.425
Proportion with MEDD > 120 b 0.137 − 0.002 (− 0.001, − 0.004) 0.249 0.215 −0.004 (− 0.002, − 0.005) 0.045 −0.001 (0.003, − 0.006) 0.624
Proportion with co-prescribed benzodiazepines b 0.055 0.001 (− 0.006, 0.008) 0.654 0.080 − 0.001 (0.006, − 0.007) 0.637 − 0.002 (0.000, − 0.003) 0.019
  1. aThree or more opioid prescriptions in each of the most recent 3 months
  2. bSubset of proportion a above (patients with three or more opioid prescriptions in each of the most recent 3 months)
  3. cMEDD morphine-equivalent daily dose (for patients with consistent opioid Rx)